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Background: In recent years community-based voluntary counselling and testing sites (CB-VCT) for men having sex
with men (MSM) have been established in larger cities in Germany to offer more opportunities for HIV testing.
Increasingly, CB-VCTs also offer testing for other bacterial sexually transmitted infections. In Hamburg, tests in
CB-VCTs are offered free and anonymously. Data on demographics and sexual risk behaviours are collected with
a paper questionnaire.
Methods: Questionnaire data from the MSM CB-VCT in Hamburg were linked with serological test results for
HIV and syphilis, and with rectal and pharyngeal swab results for gonorrhoea and chlamydia. MSM were defined
as males reporting male sex partners. CB-VCT clients were characterized demographically, and associations between
sexual behaviour variables and diagnosis of HIV and sexually transmitted infections (STI) were analysed by bivariate
and multivariate logistic regression analysis.
Results: Among the male clients of the CB-VCT in 2011–2012 who were tested for HIV or any STI 1476 reported male
sex partners. Unprotected anal intercourse (UAI) was reported as reason for testing by 61% of the clients. Forty-one
of 1413 clients testing for HIV were tested positive (2.9%). Twenty-four of 1380 clients testing for syphilis required
treatment (1.7%). Tests for simultaneous detection of N. gonorrhoea and Chlamydia trachomatis were conducted on
882 pharyngeal and 642 rectal swabs, revealing 58 (=6.6%) pharyngeal and 71 (=11.1%) rectal infections with one or
both pathogens. In multivariate logistic regression analysis number of partners, UAI (OR=2.42) and relying on visual
impression when selecting sex partners (OR = 2.92) were associated with increased risks for diagnosis of syphilis or a
rectal STI. Syphilis or rectal STI diagnosis (OR=4.52) were associated with increased risk for HIV diagnosis.
Conclusions: The MSM CB-VCT in Hamburg reaches clients at high risk for HIV and STIs. The diagnosis of syphilis or a
rectal STI was associated with increased odds of testing positive for HIV. Due to the high prevalence of curable
bacterial STI among clients and because syphilis and rectal bacterial STI may facilitate HIV transmission, MSM asking
for HIV tests in CB-VCTs should also be offered tests for other bacterial STIs.
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In recent years community-based voluntary counselling
and testing sites (CB-VCT) [1] for HIV have been estab-
lished for MSM in larger cities in Germany. One of these
CB-VCTs is “Hein&Fiete” in the city of Hamburg.
Hein&Fiete was founded in 1990 as an HIV prevention
project for MSM. It includes a community drop-in
centre with daily opening hours, providing information
on gay life in Hamburg, meeting spaces for community
groups, outreach prevention work for MSM, HIV and
STI serological testing since 2004, and STI swab testing
with nucleic acid amplification tests since 2011. The staff
consists of approximately 85 volunteers and 5 full or
part-time paid staff members. The work of Hein&Fiete,
including free testing for HIV and STIs, is funded by the
Federal state of Hamburg and by donations.
As low-threshold (anonymous, gay-friendly, low-cost)
sexually transmitted infection (STI) screening opportun-
ities for MSM are scarce in the German health care
system [2], STI tests, particularly serological tests for
syphilis and nucleic acid amplification tests for gonor-
rhoea and chlamydia infections, are increasingly offered
by CB-VCTs. Since these tests can be provided free of
charge, uptake of STI tests at Hein&Fiete is the highest
among German CB-VCT. To facilitate the pre-test coun-
selling session, clients of CB-VCT sites are invited to fill
out an anonymous paper-based and standardized ques-
tionnaire on demographics, testing history, transmission
risks, and risk management strategies. We analysed these




Tests for HIV, HBV, HCV, syphilis, gonorrhoea and
Chlamydia trachomatis were offered anonymously and
free of charge. Decisions on which tests to take were
based on pre-test needs counselling and the clients’ own
choice. “Hein&Fiete” provides only testing and counsel-
ling and needs to refer clients with an infection diagno-
sis for further treatment to a private practice or hospital.
Because most urethral infections with gonorrhoea and
chlamydia in men are expected to be symptomatic, test-
ing for urethral infections with these pathogens is
not prioritized, while tests for the mostly asymptomatic
pharyngeal and rectal infections are offered. Counsellors
recommended pharyngeal and rectal swabs particularly to
clients who reported higher numbers of sex partners.
Clients were invited to receive their test results two to
five days after testing. In case of a positive test result,
adequate therapy options were provided through referral
to specialized MSM-friendly physicians.
Questionnaires and test results were entered in a
Microsoft Access database by Hein&Fiete staff.Data were fully anonymized and the anonymous code
used at the CB-VCT was exchanged with another unre-
lated code. Therefore, ethical approval to conduct this
analysis was waived.
Study sample
Study population were all MSM clients attending the
CB-VCT of “Hein&Fiete” who were tested for at least
one STI (Chlamydia trachomatis, gonorrhoea, HIV,
syphilis) and who completed the standardized question-
naire in 2011 and 2012. Men were defined as MSM if
they reported at least one male sex partner in the previ-
ous 12 months.
Measurements
Using a 25 item questionnaire, Hein&Fiete collected data
on demographics (age, migration status, education), sex-
ual orientation and partnerships, number and gender of
sex partners in the previous 12 months, place where sex
partners were met, use of drugs in combination with
sex, testing history and test results for HIV and STIs,
reasons for testing, condom use and reasons for not
using condoms, and risk management strategies other
than condom use.
Clients were tested for HIV with the Abbott Architect
HIVAg/Ab Combo assay, reactive samples were confirmed
by Mikrogen, recomLine HIV-1 & HIV-2 IgG testing. For
syphilis testing, samples were screened by Abbott Architect
Syphilis TP Reagent, and confirmed by a quantitative
TPPA test (MAST). Active infection was defined as either
detection of anti-treponemal IgM (Mikrogen, recomWell
Treponema IgM) or a positive test for Cardiolipin-KBR
(Virion). Pharyngeal swabs taken by medical personnel and
rectal swabs taken by the clients themselves were tested
for gonorrhoea (Gc) and Chlamydia trachomatis (CT) with
the BD ProbeTec™ ET System, which uses strand displace-
ment amplification (SDA) for real-time detection of CT/GC.
Statistical analysis
The data were analysed using SPSS© (Version 20, IBM
Corp.). We used descriptive statistics, calculated bivari-
ate correlations for reporting UAI, being diagnosed with
a rectal STI or syphilis, or being diagnosed with HIV,
with odds ratios, 95% confidence intervals (CI) and
p-values, and constructed three models for multivariate
logistic regression analyses to identify factors associated
with reporting UAI (principal mode of HIV transmission
among MSM), diagnosis of a rectal STI or syphilis (both
cofactors for acquiring HIV), and factors associated with
diagnosis of HIV. Meeting places were used as binary
variables (yes/no). Age and partner number were in-
cluded as categorical variables (<30 years, 30–44, >44; 0–
2 partners, 3–5, 6–10, >10) in all three models (for
the age grouping see [3]). Additional factors were only
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cant (p < 0.10) in bivariate analysis. The method used was a
conditional forward inclusion (p < 0.05) and backward
elimination (p > 0.10) procedure. Reasons for not using
condoms during a recent risk situation and risk manage-
ment strategies other than condom use were not included
in the multivariate model for UAI, only in the models for
STI and HIV diagnosis.
Results
A total of 1630 persons filled in a questionnaire at
Hein&Fiete in 2011 or 2012. Of these, 1565 men
reported on the gender of their sexual partners. There
were 1506 men identifiable as MSM. Since not all men
filling out the questionnaire were actually tested - some
clients were only counselled and some were recommended
to get tested later because reported risks were too recent -
the final sample for this analysis consisted of 1476 men
reporting male partners and having been tested for at least
one infection. HIV was tested for most frequently (1413),
followed by syphilis (1380), pharyngeal (882) and rectal
(642) infections with gonorrhoea and chlamydia. Accord-
ing to self-reported previous test date and place, up to 295
men were tested at least twice at Hein&Fiete during the
two years. Numbers and proportions testing positive for
the respective infections are presented in Table 1.
The clients having been tested more than once during
the two-year observation period may impact the number
and proportion of clients testing positive for treponemal
antibodies. Based on antibody detection, the new or
re-infection rate for syphilis between the repeated tests
cannot be determined, and the same individuals may be
counted twice or more.
The completeness of core variables in the MSM sam-
ple ranged from 82% (response to question on previousTable 1 HIV and STI test results of MSM clients, 2011-2012
Number of tests
(any test N = 1476)#
Number (%)
positive
HIV 1413 41 (2.9)
Syphilis (active) 1380 27 (2.0)
Syphilis (antibodies) 1380 131 (9.5)
Gonorrhoea rectal 642 23 (3.6)
Gonorrhoea pharyngeal 882 48 (5.4)
Chlamydia rectal 642 56 (8.7)
Chlamydia pharyngeal 882 15 (1.7)
Any rectal STI 642 71 (11.1)
Any rectal STI or active syphilis 1403 95 (6.8)
# discrepancies of numbers compared with Figure 1 due to missing age data for 40
n.a. =not applicable, because treponemal antibodies often persist after treatment. A
treponemal antibodies. Since the result of the previous tests is unknown, new or re
*= 295 had been tested at Hein&Fiete, 191 had been tested elsewhere first and the
°= clients had been tested at Hein&Fiete at least twice in 2011–2012, however it is uchlamydia testing) to 99.9% (sexual orientation). Infor-
mation e.g. on risk behaviour (unprotected intercourse)
and HIV test results were available for approximately
1300 clients, information on rectal STI and risk behav-
iour for approximately 600 clients.
The median age of the respondents was 36 years
(interquartile range: 28–45 years). A migration back-
ground (parents or respondent himself immigrated to
Germany) was reported by 25% of the respondents. A
high school diploma or a higher degree of education
was held by 69%. Twelve percent of the sample self-
identified as bisexual, 87% as gay. Relationship status at
the time of testing was reported as single by 53% of the
respondents; another 22% reported being in an open and
25% reported being in a mutually exclusive relationship.
A previous test for HIV was reported by 87% of the
tested MSM, a previous syphilis test by 59%, 37% had
been tested for gonorrhoea, and 31% for Chlamydia tra-
chomatis (both not differentiated by location).
Overall, MSM clients reported a median of 6 and a
mean of 11 sexual partners (standard deviation 18) in
the previous twelve months. The pharyngeal swab sub-
sample reported a median of 7 and a mean of 13 part-
ners (standard deviation 21), the rectal swab subsample
a median of 8 and a mean of 14 partners (standard devi-
ation 24), reflecting the preferential recommendation to
take swabs for clients with higher partner numbers.
Transmission risk behaviour, particularly in terms of
HIV risks, was queried by a question asking for the rea-
sons for testing. Unprotected anal intercourse (UAI) was
reported by 61% of the clients as a reason for testing;
44% reported insertive UAI, and 35% reported receptive
UAI. Unprotected oral intercourse with ejaculation
into the mouth was reported as risk factor by 33% of












mong the clients reporting testing at least twice 28 (10.3%) had detectable
-infection rates could not be determined.
second time at Hein&Fiete.
nknown whether they had been tested twice for this STI or at this location.
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(27 out of 71 = 38%). The context in which risks were
taken could be derived from questions on drug and alcohol
use before or during sex (completed by 65%) and from a
question on where most sex partners were met. Bivariate
associations of these factors with UAI, STI and HIV diag-
nosis are shown in Table 2.
Acute syphilis and HIV diagnoses were almost equally
distributed across all age groups in the tested sample.
MSM diagnosed with HIV were younger than MSM
diagnosed with acute syphilis. Noticeably, while within
age groups those men who were diagnosed with rectal
or pharyngeal gonorrhoea or chlamydia reported higher
numbers of partners, though the differences were statis-
tically not significant, across the whole sample the
median number of partners increased with age (from a
median of 5 for age <30 years to a median of 10 for age
45–59), while the proportion of clients diagnosed with
gonorrhoea and chlamydia decreased (Figure 1). Please
note that numbers do not sum up to the numbers in
Table 1 due to missing age data of 40 clients.
Clients reporting a self-perceived risk situation as a
reason for testing (compared to routine testing or testing
when entering a new partnership) were significantly more
likely to be diagnosed with HIV and STI (OR = 2.8; 95% CI
1.4-5.6). In bivariate analysis, reported reasons positively
associated with risk situations were reluctance of the sex
partner to use a condom and unavailability of condoms at
a sexual encounter (see Table 2).
Among the risk management strategies besides con-
dom use, asking the active partner to withdraw before
ejaculation and asking the partner about his HIV status
were positively associated with being diagnosed with a
bacterial STI or with HIV (Table 2).
Reported UAI was strongly associated with an HIV
diagnosis and less strongly associated with the diagnosis
of a rectal STI or syphilis. The concomitant diagnosis of
a rectal infection with gonorrhoea or chlamydia or a
diagnosis of syphilis was strongly associated with an HIV
diagnosis. For clients reporting an HIV positive partner
the odds ratio for being diagnosed with HIV was 1.8
(95% CI 0.8-4.1; p = 0.175) compared to others, which
did not reach statistical significance.
In multivariate logistic regression analyses including age
and partner numbers (significantly associated with UAI
and STI diagnoses in bivariate analysis) in addition to
reported substance use and risk management strategies
(the latter not included for UAI, but only for STI and HIV
diagnosis outcomes) showing statistical significance in
bivariate analysis, the following factors remained signifi-
cantly associated (results see also Table 2)
with UAI: age group, a high partner number, and use
of inhaled amyl nitrite (poppers);with diagnosis of a rectal STI or syphilis: high partner
numbers, reporting use of ecstasy when having sex,
reporting UAI, and having sex only with partners who
appear healthy;
with HIV diagnosis: diagnosis of rectal gonorrhoea or
chlamydia infection or diagnosis of syphilis; asking
the active partner to withdraw before ejaculation.
The odds ratio for being diagnosed with HIV when
reporting UAI was 2.8, but this did not reach
statistical significance (95% CI 0.8-10.1).
Discussion
The data show that the CB-VCT site in Hamburg
reached MSM at high risk for HIV and bacterial STI.
Though a cost-effectiveness analysis was not conducted,
considering the high prevalence and low overhead costs
of the CB-VCT site, testing at the CB-VCT is likely a
very cost-effective way of reducing the proportion of
undiagnosed HIV and STI infections in this population
compared to untargeted screening in medical facilities
and also compared to untargeted VCT sites [4-9]. How-
ever, well-educated and self-identified gay men were
reached disproportionally: a high school diploma or a
higher degree of education was held by 69%, compared
to 35% in the German general population and 60% in a
recent MSM online survey (“Gay men and AIDS 2013”-
GMA 2013, unpublished observations). Eighty seven
percent self-identified as gay, while large population-
based surveys suggest a proportion of non-gay-identified
MSM which is clearly higher than 13% [10]. Thus, to
reach a broader spectrum of MSM, the current CB-VCT
approach may need to be combined with other ap-
proaches to reach MSM who are less well educated and
less out about their sexual preferences than the clients
reached by Hein&Fiete.
Many CB-VCT sites in Europe so far only offer HIV
testing, sometimes in combination with syphilis screen-
ing. The Hamburg experience, finding higher prevalence
for rectal and pharyngeal infections with gonorrhoea or
chlamydia than for syphilis or HIV (though in a more
preselected subsample) convincingly argues for the com-
bination of HIV and STI testing for MSM. Our data
show that a more comprehensive offer to screen for all
relevant bacterial STIs is warranted for this population.
While testing costs have not been an issue so far in
Hamburg where tests are covered by public funds,
nucleic acid amplification tests for gonorrhoea and chla-
mydia may increase testing costs considerably, particularly
when all three possibly affected sites (urethra, pharynx,
and rectum) are screened. One option to minimize costs
might be the use of pooled combination tests, i.e. pooling
pharyngeal, rectal and urethral swabs or a urine specimen
for analysis and using combination tests for gonorrhoea
Table 2 Results of Bi- und Multivariate analysis of associations between age, partner numbers, meeting places with
sex partners, substance use during sex, biological cofactors and risk behaviours with the outcomes UAI, rectal STI and
HIV diagnosis
Bivariate Multivariate Bivariate Multivariate Bivariate Multivariate
UAI STI rectal or syphilis HIV
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age group
<30 1.54*** 1.18-1.96 1.67*** 1.26-2.23 1.78** 1.12-2.86 1.06 0.49-2.33
30-44 (ref.) 1 1 1
>44 years 1.11 0.86-1.43 0.87 0.49-1.54 1.27 0.58-2.80
Partner number
0-2 (ref.) 1 1 1
3-5 1.15 0.80-1.64 2.71 0.76-9.66 1.41 0.48-4.14
6-10 1.18 0.83-1.70 6.10*** 1.82-20.41 6.13*** 1.79-20.9 0.82 0.25-2.72
>10 1.59*** 1.12-2.25 5.06*** 1.51-16.91 5.27*** 1.55-18.0 0.91 0.30-2.83
Meeting sex partners
At friends 1.20 0.93-1.47 1.31 0.85-2.02 0.47* 0.21-1.06
In bars 1.02 0.81-1.28 0.95 0.60-1.49 0.84 0.42-1.69
In gay bathhouses 1.05 0.83-1.32 1.25 0.80-1.95 1.08 0.55-2.15
In porn cinemas 1.07 0.81-1.42 1.11 0.65-1.89 1.83* 0.90-3.71
In outside cruising sites 1.02 0.71-1.47 0.66 0.28-1.53 1.10 0.39-3.13
On highway resting areas 1.29 0.67-2.46 1.51 0.53-4.33 0.90 0.12-6.74
Online 1.49*** 1.20-1.84 1.29** 1.01-1.65 1.45* 0.93-2.26 0.81 0.44-1.52
At parties or discotheques 1.41*** 1.12-1.78 0.94 0.60-1.48 0.61 0.29-1.29
In public urinals 1.55 0.73-3.26 1.34 0.40-4.48 0.97 0.96-0.98
In fitness centres 1.12 0.75-1.69 0.68 0.27-1.71 0.31 0.04-2.26
Substance use
Alcohol 1.32*** 1.07-1.62 0.82 0.54-1.24 0.63 0.34-1.17
Inhaled Amyl nitrite 1.68*** 1.31-2.15 1.63*** 1.23-2.17 1.04 0.65-1.67 1.67 0.88-3.19
Sildenafil 1.53* 0.96-2.43 1.22 0.55-2.72 1.20 0.36-3.95
Cocaine, Speed 1.65* 0.93-2.91 2.36** 1.09-5.15 1.21 0.28-5.12
Cannabis 1.50* 0.97-2.30 1.23 0.58-2.62 1.04 0.32-3.42
Ecstasy 3.54 0.78-16.03 4.23* 1.15-15.65 5.77** 1.40-23.8 2.83 0.36-22.32
GBL,GHB 0.61** 0.58-0.63 4.67* 0.93-23.44 4.88 0.59-40.56
Cofactors, behaviours
Unprotected anal intercourse n.a. 2.39*** 1.46-3.93 2.42*** 1.29-4.53 4.52*** 1.76-11.59 3.24* °
STI co-diagnosis n.a. n.a. 3.02** 1.22-7.46 4.52*** 1.68-12.1
Having sex with partners
who appear healthy
n.a. 3.09*** 1.94-4.92 2.92*** 1.68-5.07 1.27 0.56-2.91
Asking the insertive partner
not to ejaculate inside
n.a. 2.11** 1.16-3.86 4.34*** 2.11-8.89 4.44*** 1.75-11.3
Asking the partner about
HIV status
n.a. 1.71** 1.03-2.85 2.03* 1.00-4.11
Partner reluctant to use
condoms
n.a. 1.30 0.72-2.34 2.68** 1.32-5.45
No condom available n.a. 2.81** 1.46-5.41 3.10** 1.26-7.60
*p > 0.05 < =0.10; **p < =0.05 > 0.01; ***p < =0.01.
n.a. = not applicable.
°Results of Multivariate logistic regression only reported if p < =0.05 (except for UAI as risk factor for HIV diagnosis, p = 0.07).










































n HIV 158 259 212 204 190 158 116 78
n rectal 71 107 83 96 92 86 65 21
n pharyngeal 104 150 119 128 120 106 86 43
n Syphilis 152 238 205 196 188 159 122 81
Figure 1 Proportion of MSM testing positive for different STIs and HIV, by age groups.
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reported sexual risks could be another option. However, a
large proportion of clients who were diagnosed with a rec-
tal STI did not report receptive UAI. Reasons for this may
be responses biased by social desirability to underreport
UAI in general as well as a lack of questions that would
cover all possible modes of transmission of bacterial STI
to the rectal mucosa beyond insertive UAI.
We found an interesting inverse association between
median numbers of partners and the proportion of rectal
and pharyngeal infections with gonorrhoea and chla-
mydia by age group: although MSM from older age
groups reported higher median numbers of partners,
they were less likely to be diagnosed with rectal or
pharyngeal infections. Similar observations have already
been reported by other authors [12,13]. However, within
the same age groups MSM who were diagnosed with
rectal or pharyngeal infections reported higher median
numbers of partner than MSM who were not diag-
nosed with an infection. This is reminiscent of the age-
dependence of chlamydia diagnoses in women, which
might be explained by an evolving immunity to this patho-
gen by repeated exposures over time [14]. Other reasons
for this inverse association could be differences in condom
use or partner selection for anal intercourse without a
condom by age group. However, lack of condom use
would not explain the differences for pharyngeal infec-
tions, since condoms are very rarely used for oral inter-
course regardless of age group.
The associations we found between risk management
strategies aiming at identifying partners infected and di-
agnosed with HIV and outcomes such as UAI, rectal STI
or HIV diagnosis may reflect how widespread these riskmanagement strategies are, that they are ineffective for
avoiding other STI, and that even their utility to avoid
HIV infection may be very limited. A high proportion of
MSM diagnosed with HIV receives antiretroviral treatment
and may thus be only minimally infectious, while most
men who are still infectious are not yet diagnosed and thus
not identifiable by respective questions. Our finding of a
non-significant association of testing HIV positive when a
partner is known to be infected with HIV is in contrast to
a very high hazard ratio for testing HIV positive when
reporting unprotected anal intercourse with a known HIV
positive partner in the United States-based EXPLORE
study conducted from 1999 through 2003 [15]. The main
explanation for this discrepant finding may be the in-
creased treatment rate among MSM in Germany com-
pared to the situation in the United States ten years ago.
Contrastingly, men who have multiple partners and
rely predominantly on HIV serosorting instead of con-
dom use for protection against HIV transmission may
be more likely to meet partners using the same risk
management strategy. Once HIV is present in sexual
networks using this risk management strategy, it may
spread quite efficiently, particularly because other bac-
terial STIs accumulating in these networks are further
enhancing HIV transmission. Alternatively or additionally,
rectal STIs may just be a marker for risk behaviours or net-
works with increased HIV transmission risks. Other STIs,
particularly rectal STIs, have been reported to be associ-
ated with an increased risk of acquiring HIV, e.g. by a
group from New York in a longitudinal study design [16].
The association of STI diagnosis (rectal STI or syphilis)
with the risk management strategy ‘having sex only with
partners who appear healthy’ in multivariate regression
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even less visible than HIV infection. Relying on visual
appearance is therefore particularly ineffective for avoiding
STI infections. The strong association between HIV diag-
nosis and the risk management strategy of asking the active
partner to withdraw before ejaculation is difficult to inter-
pret: the format of the question leaves open whether this
strategy refers to oral or anal intercourse or both. Since a
causal association with HIV transmission is conceivable
only for anal intercourse, this association might be con-
founded. Asking for withdrawal could just be a surrogate
for other unmeasured characteristics or risk management
strategies of men at increased risk for HIV.
Another interesting finding is the subtle discrepancy
between meeting places as risk factors for STI and for
HIV diagnosis in the bivariate analysis, considering only
the results which reached borderline statistical signifi-
cance. While discrepancies in statistical significance
regarding risk factors may just be due to the lower
numbers of HIV compared to STI diagnoses, it could also
be an indication of subtle differences regarding HIV and
STI transmission risks in different settings. High STI
transmission risks would be expected in settings with low
condom use due to high probability of HIV serostatus
communication (e.g. when meeting partners online and
in private settings [17]. High HIV transmission risk was
associated with meeting partners at porn cinemas, which
in Hamburg is probably the most popular sex-focused
gay venue with only minimal serostatus communication.
There are of course several limitations to this investi-
gation: the questionnaire was primarily designed to
facilitate clients’ sexual-health counselling needs, not to
systematically detect specific risk factors. Associations we
detected, particularly between risk management strategies
and STI and HIV diagnosis, may therefore be confounded
by other, unmeasured factors. It is likely that some ques-
tions were answered with regard to recent situations
where respondents assumed risks; however this does not
necessarily mean that HIV or STIs were transmitted dur-
ing these encounters. The use of a combined outcome
(rectal STI or syphilis), in which the number of men tested
for rectal STI was less than half of the number of men
tested for syphilis weakens associations, because many
rectal STIs may have remained undiagnosed. Using only
rectal STI as outcome changes some of the associations in
bivariate analysis, but has no substantial impact on the
variables remaining significant in multivariate analysis
(data not shown). A social desirability bias, particularly re-
garding the reporting of unsafe sexual practices and drug
use, should be expected, since the responses were known
to be discussed with a sexual-health counsellor. That UAI
was not significantly associated with HIV diagnosis in the
multivariate regression model may be an indication of
UAI underreporting. Lastly, with its focus on commonsexual practices among MSM, the scope of sexual prac-
tices that could possibly result or contribute to the trans-
mission of bacteria to the rectum or pharynx was not fully
explored [18].
Conclusions
Our results emphasize the need to combine HIV and
STI testing for MSM and the need for comprehensive
screening for mostly asymptomatic rectal and pharyngeal
infections [19]. Community-based VCTs can reach the
MSM target group quite efficiently, and offering compre-
hensive HIV and STI testing in this setting is likely to be
much more cost effective than relying on traditional health
care settings. However, the CB-VCT approach for MSM is
likely only feasible in larger cities with respective gay com-
munities. Additional alternative approaches will be neces-
sary to reach rural MSM, MSM less connected to the gay
community, and MSM less willing to self-identify as gay.
Behavioural data which may be useful to adapt and fine-
tune prevention messages for MSM can also be collected
in this setting. The data collected routinely before the
counselling session appears quite useful for the analysis of
risk behaviours and trends in risk management strategies,
especially combined with testing data.
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